Ozawa, Hiroki
Kawakubo, Hirofumi
Kitagawa, Yuko
Article History
Received: 28 December 2020
Accepted: 28 December 2020
First Online: 5 March 2021
Disclosure
: Dr. Kitagawa reports grants from Chugai Pharmaceutical Co., Ltd., grants from Taiho Pharmaceutical Co., Ltd., grants from Yakult Honsha Co. Ltd., grants from Asahi Kasei Pharma Corporation, grants from Otsuka Pharmaceutical Co., Ltd., grants from Takeda Pharmaceutical Co., Ltd., grants from Ono Pharmaceutical Co., Ltd., grants from Tsumura & Co., grants from Kyouwa Hakkou Kirin Co., Ltd., grants from Dainippon Sumitomo Pharma Co., Ltd., grants from EA Pharma Co., Ltd., grants from Astellas Pharma Inc., grants from Toyama Chemical Co., Ltd., grants from Medicon Inc., grants from Kaken Pharmaceutical Co., Ltd., grants from Eisai Co., Ltd., grants from Otsuka Pharmaceutical Factory, Inc., grants from Teijin Pharma Ltd., grants from Nihon Pharmaceutical Co., Ltd., grants from Nippon Covidien Inc., and grants from Shionogi & Co., Ltd, outside the submitted work.